Add Company
Join Now

Sharp Rees-Stealy Medical Group Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Medical Practices

Industry

Employee Data

  • Sharp Rees-Stealy Medical Group has 707 Employees.(i)
  • Sharp Rees-Stealy Medical Group grew their employee count by 19% last year.

Sharp Rees-Stealy Medical Group's People

NameTitleEmail/Phone
1
Chief Pulmonary MedicineReveal Email/Phone
2
CCOO - Chief Clinical Operations OfficerReveal Email/Phone
3
Associate Division ChiefReveal Email/Phone
4
Chief Population Health OfficerReveal Email/Phone
5
Chief Medical OfficerReveal Email/Phone
6
Division ChiefReveal Email/Phone
7
Administrative Chief StaffReveal Email/Phone
8
Assistant Medical Director, Managed CareReveal Email/Phone
9
Associate Medical Director - Occupational MedicineReveal Email/Phone
10
DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A2780%N/AN/A
#2
N/A20-5%N/AN/A
#3
N/A16625%N/AN/A
#4
N/A605%N/AN/A
#5
N/A113304%N/AN/A
#6
N/A708%N/AN/A
#7
N/A10654%N/AN/A
#8
N/A4033%N/AN/A
#9
$3.5M24719%N/AN/A
#10
N/A2840%N/AN/A
Add Company

What Is Sharp Rees-Stealy Medical Group?

As one of the largest, most comprehensive medical groups in San Diego County, our 19 locations offer services such as primary and specialty care, laboratory, physical therapy, radiology, pharmacy and urgent care. Founded in 1923, Sharp Rees-Stealy has some 700 physicians and advanced practice providers and 2,800 staff members who represent virtually every field of medicine. Each team member is dedicated to delivering the extraordinary level of care called The Sharp Experience, which combines clinical excellence, advanced technology and patient- and family-centered care.

keywords:N/A

N/A

Total Funding

707

Number of Employees

N/A

Revenue (est)

19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$163.8M709N/AN/A
#2
$253.9M7146%N/A
#3
$177.6M71613%$62.1M
#4
$35M71749%N/A
#5
$270.4M7217%N/A